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ABSTRACT : Nuclear DNA patterns were evaluated for 115 lung cancers which were 
surgically resected. Seventeen percent showed diploidy pattern and 83% were aneuploidy. 
 The 3-year survival was 90% in those who showed diploid and 58% in those who revealed 
aneuploid in analysis of nuclear DNA patterns. In conclusion determination of nuclear 
DNA pattern for lung cancer cells is of clinical value to assess the surgical outcome besides 
the histochemical evaluation.
       INTRODUCTION 
 The nuclear deoxyribonucleic acid (DNA) 
content of tumor cells has been applied for 
assessment of the prognosis or determination 
of the treatment of malignant tumors') ,'). It is 
widely accepted that nuclear DNA contents 
reflect the biological characteristics of tumors 
in terms of their malignancy which implies a 
higher rate of recurrence and metastasis. 
Histologically stromal reaction is generally re-
garded as host resistance against tumor 
infiltratin around healthy tissues and lymphatic 
or hematogenous metastases. Some investi-
gators confirmed that a prominent lympoid 
infiltration around tumors was associated with 
a favorable prognosis in patients with gastric 
or colonic carcinomas"". 
 The purpose of this study is to clarify as to 
whether the prognosis for patients who 
undrewent surgical resections correlate with 
nuclear DNA of lung tumor cells or not and as 
to whether surgical outcome including the 
survival time following surgery is accurately 
anticipated in terms of nuclear DNA analysis 
on the basis of a result of our experience.
   MATERIALS AND METHODS 
 Nuclear DNA patterns in the surgical 
specimens resected for the treatment of lung 
cancer were analyzed from paraffin-embedded 
preparation by uisug FACS IV. 30,um section, 
cut from formalin-fixed and paraffin-embedded 
tissue blocks, were dewaxed (by xylen) rehydrate 
(100% to 50% ethanol) and then washed by 
immersing in the running tap water. The 
sample that was confirmed to be an adequate 
part by the hematoxylin stained section was 
incubated overnight in trypsin-citrate buffer and 
stained using Solution A (trypsin), Soluition B 
(trypsin inhibitor, RNase A) and Solution C 
(spermine tetrahydrochloride propidium iodide), 
and the values of the peak channel numbers of 
normal and cancer cells were measured by using 
FACS IV. DNA index was calculated according 
to a following equation, DNA index=peak 
channel number of cancer cells/peak channel 
number of normal cells. 
 Nuclear DNA patterns were evaluated in 115 
patients with resected lung cancers as shown 
in Table 1. Most of them (82.6%) showed a 
pattern of aneuploidy. It was not characteristic 
of histologic types.
 Table 1. 'Tumor cell DNA ploidy pattern 
 histology PATIENTS (%) Total             di
ploidy aneuploidy 
  ad. ca. 8(16.3) 41 (83.6) 49( 100) 
  sq. ca. 12 (18.3) 52 (81.2) 63( 100) 
larg. cell. ca. 0 ( 0) 2(100) 2 ( 100) 
            20 (17.4) 95 (82.6) 115( 100)
Table 2. Comparison in 3-year survival between 
       types of histology and DNA pattern 
 histology 3-year survival                   diploid  
aneuploidy 
ad. larg. ca N=51 88% 58% p<0.05 
  sq. ca N=64 91% 58% p<0.05
 The three-year survival between patients with 
diploidy and aneuploidy of nuclear DNA pattern 
was compared in this series. 
 In adenocarcinoma and large cell carcinoma 
of histologic types, 88% of those who disclosed 
the DNA pattern of diploidy survived 3 years 
or more although 58% of those who demostrated 
aneuploidy survived more than 3 years. In 
contrast, in squamous cell carcinoma, 91% of 
those who demonstrated diploidy did well more 
than 3 years in spite of 58% out of aneuploidy. 
These were statistically significant difference 
(p<0.05) between the patients with DNA 
patterns of diploidy and aneuploidy. 
 On the other hand, a limited operation for 
small-sized lung cancers of the peripheral type 
was applied for surgical treatment. However, 
their prognoses were not uniform, some were 
satisfactory, some were disappointed. 
 When nuclear DNA patterns were analyzed, 
their prognoses were apparently divided into the 
two groups, better group included diploidy of 
nuclear DNA pattern and worse one mainly 
holded aneuploidy of nuclear DNA as shown in 
Table 2.
         DISCUSSION 
 In general, nuclear DNA analysis of tumor 
cells helps physicians to expect the prognosis 
and know aggressiveness of tumor cells. It is 
generally known that aneupliod pattern of 
tumor cells means high potential of aggressive 
behavior of the tumor.
 The analysis of nuclear DNA content from 
paraffin-embedded tissue blocks makes it 
possible to do retrospective analysis of patients 
who clarify the survival time. 
 It is accepted that DNA pattern correlates with 
the prognosis of malignant tumor-bearing or 
surgical patients. 
 The prognosis of lung cancer is not yet 
satisfactory except for early cancer. It is 
believed that aggressiveness of lung cancer cells 
is much more increased than that of the other 
malignant tumor cells. In this study, it is a 
clarified fact that DNA pattern of aneuploidy 
in lung cancer cells is a dominanat diploidy 
pattern in the analysis of nuclear DNA. 
 On the other hand, most of those in whom 
aneuplpidy pattern was evidenced failed to 
survive more than 3 years with statistically 
significant difference(p<0.05) regardless of 
histologic types. 
 In fact, nuclear DNA pattern clearly indicates 
as to whether the prognosis and surgical 
outcome of lung cancer patients would be fair 
or not. Therefore, it is recommended that 
aggressive operation and adjuvant therapy are 
required for patients with aneuploidy pattern 
in nulcear DNA analysis. It is noteworthy that 
nuclear DNA analysis is of great benefit as well 
as great value to assess their prognoses and to 
determine the necessity or aggressive adjuvant 
therapy for obtaining a long-term suvival.
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